Advancing Complementary Goals
Integral to GAPPS’ global harmonization effort is connecting with projects that share similar goals and coordinating our work across disciplines, working together to find answers from discovery to development to delivery. Through collaboration we hope to eliminate duplication of effort, discover areas for possible harmonization, and promote synergy towards a collective knowledge that will lead to better birth outcomes. The following initiatives support our goals:
- GONet (Global Obstetrics Network) A collaborate group of international investigators that perform clinical trials and observational studies in maternal fetal medicine and obstetrics. The group was formed to bring together those performing similar studies to exchange information and explore areas for collaboration.
- PremUp The Foundation for Scientific Cooperation on Pregnancy and Prematurity (PremUp) is composed of 100 independent researchers representing 16 areas of research. Studies include the maternal environment’s influence on placental function, the physiopathology of premature delivery and cerebral and pulmonary lesions in the premature baby, predictive biomarkers and new tools for medical imaging.
- INTERGROWTH-21st The University of Oxford is directing this effort focused on developing standards describing optimal fetal growth, preterm growth and newborn nutritional status in eight geographically diverse populations. Their goal is to produce new international fetal, newborn and preterm postnatal growth standards. GAPPS is consulting with INTERGROWTH-21st in developing a specimen collection for a supplementary study focusing on a wider population: InterBio.
- PREBIC The International Preterm Birth Collaborative (PREBIC) was initiated to support and enhance international networking among researchers in preterm birth, and to establish multinational research projects on preterm birth.
- CoLaboratory The Global Pregnancy CoLaboratory is a research and academic medical center consortium that brings together investigators to share pregnancy clinical data and biological samples for collaborative studies related to adverse pregnancy outcomes, with a special focus on preeclampsia.